Annals of Nuclear Medicine最新文献

筛选
英文 中文
Reply to "Methodological and clinical considerations on predicting PSMA-positive metastatic disease in early biochemical failure after radical prostatectomy: comment on Santo et al." 回复“预测根治性前列腺切除术后早期生化失败患者psma阳性转移性疾病的方法学和临床考虑:对Santo等人的评论。”
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-04-13 DOI: 10.1007/s12149-026-02215-y
Giulia Santo, Francesco Grillone, Giuseppe Lucio Cascini, Francesco Cicone
{"title":"Reply to \"Methodological and clinical considerations on predicting PSMA-positive metastatic disease in early biochemical failure after radical prostatectomy: comment on Santo et al.\"","authors":"Giulia Santo, Francesco Grillone, Giuseppe Lucio Cascini, Francesco Cicone","doi":"10.1007/s12149-026-02215-y","DOIUrl":"https://doi.org/10.1007/s12149-026-02215-y","url":null,"abstract":"","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147670146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PSMA PET/CT imaging for biochemical recurrence in prostate cancer: can it replace conventional imaging and guide salvage therapy? 前列腺癌生化复发的PSMA PET/CT成像:能否取代常规影像学指导挽救治疗?
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-04-13 DOI: 10.1007/s12149-026-02192-2
Efrah Ahmed Ibrahim
{"title":"PSMA PET/CT imaging for biochemical recurrence in prostate cancer: can it replace conventional imaging and guide salvage therapy?","authors":"Efrah Ahmed Ibrahim","doi":"10.1007/s12149-026-02192-2","DOIUrl":"10.1007/s12149-026-02192-2","url":null,"abstract":"<div>\u0000 \u0000 <p>Biochemical recurrence (BCR) after primary treatment for prostate cancer presents a significant clinical challenge. Conventional imaging modalities have limited sensitivity for detecting sites of recurrence, particularly at low prostate specific antigen (PSA) levels. Prostate specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) has emerged as a promising diagnostic tool that may transform the management paradigm for recurrent prostate cancer. To systematically evaluate the diagnostic performance of PSMA PET/CT in patients with biochemical recurrence of prostate cancer, compare it with conventional imaging modalities, and assess its impact on salvage therapy decisions. A systematic review was conducted following the PRISMA guidelines. PubMed/MEDLINE, Embase, Cochrane Library, and Web of Science were searched for studies published between 2020 and 2025. Studies evaluating PSMA PET/CT in patients with biochemical recurrence after primary treatment were included. The primary outcomes were detection rates stratified by PSA levels, diagnostic accuracy compared to conventional imaging, and the impact on management decisions. PSMA PET/CT demonstrated superior detection rates compared to conventional imaging across all PSA levels, with detection rates ranging from 36.2% to 96.7% for PSA levels below 0.5 ng/mL and above 5 ng/mL, respectively. In patients with negative conventional imaging, PSMA PET/CT identified true positive lesions in 64% of cases (95% CI, 56.7%-71.5%). Among patients with high-risk biochemically recurrent prostate cancer and negative conventional imaging, PSMA PET/CT detected distant metastatic disease (M1) in 46% of patients. Management plans were altered in 54-76% of cases based on PSMA PET/CT findings, with significant implications for salvage therapy targeting. PSMA PET/CT significantly outperforms conventional imaging in detecting sites of recurrence across all PSA levels, with particularly notable advantages at low PSA values. The high detection rates and accuracy of PSMA PET/CT in patients with negative conventional imaging support its role as a replacement for or complement to standard imaging protocols, while acknowledging current limitations in availability, cost, and long-term outcome data. PSMA PET/CT findings frequently alter management decisions, enabling more precise targeting of salvage therapies and potentially improving oncological outcomes.</p>\u0000 </div>","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":"40 5","pages":"469 - 479"},"PeriodicalIF":2.5,"publicationDate":"2026-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s12149-026-02192-2.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147670100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Performance of CT-guided spatial normalization for semi-quantification of dopamine transporter SPECT and detection of nigrostriatal degeneration. ct引导下空间归一化对多巴胺转运体SPECT半定量和黑质纹状体变性检测的作用。
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-04-13 DOI: 10.1007/s12149-026-02204-1
Alae Eddine El Barkaoui, Christian Scheiber, Stephane Thobois, Ralph Buchert, Marc Janier, Thomas Grenier, Anthime Flaus
{"title":"Performance of CT-guided spatial normalization for semi-quantification of dopamine transporter SPECT and detection of nigrostriatal degeneration.","authors":"Alae Eddine El Barkaoui, Christian Scheiber, Stephane Thobois, Ralph Buchert, Marc Janier, Thomas Grenier, Anthime Flaus","doi":"10.1007/s12149-026-02204-1","DOIUrl":"https://doi.org/10.1007/s12149-026-02204-1","url":null,"abstract":"","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147670063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The 68Ga-PSMA-11 PET/CT PRIMARY score for predicting pathological upgrading in ISUP grade group 1 prostate cancer: Methodological considerations and future directions. 68Ga-PSMA-11 PET/CT PRIMARY评分预测ISUP级1组前列腺癌病理升级:方法学考虑和未来方向
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-04-11 DOI: 10.1007/s12149-026-02207-y
Tian Ruan
{"title":"The 68Ga-PSMA-11 PET/CT PRIMARY score for predicting pathological upgrading in ISUP grade group 1 prostate cancer: Methodological considerations and future directions.","authors":"Tian Ruan","doi":"10.1007/s12149-026-02207-y","DOIUrl":"https://doi.org/10.1007/s12149-026-02207-y","url":null,"abstract":"","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147662191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Long-term efficacy and safety of peptide receptor radionuclide therapy in Japanese patients with unresectable neuroendocrine tumor: extension of the Japanese phase I and phase I/II study". 评论“肽受体放射性核素治疗日本不可切除神经内分泌肿瘤患者的长期疗效和安全性:日本I期和I/II期研究的延伸”。
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-04-07 DOI: 10.1007/s12149-026-02206-z
Kotina Shridevi, Megha Doiphode, Rakhi Mishra, Archana Dhyani
{"title":"Comment on \"Long-term efficacy and safety of peptide receptor radionuclide therapy in Japanese patients with unresectable neuroendocrine tumor: extension of the Japanese phase I and phase I/II study\".","authors":"Kotina Shridevi, Megha Doiphode, Rakhi Mishra, Archana Dhyani","doi":"10.1007/s12149-026-02206-z","DOIUrl":"10.1007/s12149-026-02206-z","url":null,"abstract":"","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147626812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A narrative review: key evidence from meta-analyses in nuclear medicine. 叙述性回顾:核医学荟萃分析的关键证据。
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-04-07 DOI: 10.1007/s12149-026-02201-4
Yuji Nakamoto, Mitsuaki Tatsumi, Ryuichi Nishii, Katsuhiko Kato, Yu Iwabuchi, Atsutaka Okizaki
{"title":"A narrative review: key evidence from meta-analyses in nuclear medicine.","authors":"Yuji Nakamoto, Mitsuaki Tatsumi, Ryuichi Nishii, Katsuhiko Kato, Yu Iwabuchi, Atsutaka Okizaki","doi":"10.1007/s12149-026-02201-4","DOIUrl":"https://doi.org/10.1007/s12149-026-02201-4","url":null,"abstract":"","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147626830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of shortened dynamic PET/MR protocols on D₁ receptor quantification with [11C]‑NNC112. 缩短动态PET/MR协议对[11C]‑NNC112 D₁受体定量的影响。
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-04-07 DOI: 10.1007/s12149-026-02202-3
Burak Demir, Yasemin Hoşgören Alıcı, Mine Araz, Ecenur Dursun Avcı, İrem Mesci, Halise Devrimci Özgüven, Orhan Murat Koçak, Nuriye Özlem Küçük
{"title":"Impact of shortened dynamic PET/MR protocols on D₁ receptor quantification with [<sup>11</sup>C]‑NNC112.","authors":"Burak Demir, Yasemin Hoşgören Alıcı, Mine Araz, Ecenur Dursun Avcı, İrem Mesci, Halise Devrimci Özgüven, Orhan Murat Koçak, Nuriye Özlem Küçük","doi":"10.1007/s12149-026-02202-3","DOIUrl":"https://doi.org/10.1007/s12149-026-02202-3","url":null,"abstract":"","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147626866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to the comment on “Locoregional indicators of systemic spread in breast cancer: insights from standard-of-care imaging and ¹⁸F-FDG PET/CT” 对“乳腺癌全身扩散的局部区域指标:来自标准护理成像和¹⁸F-FDG PET/CT的见解”评论的回应。
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-04-02 DOI: 10.1007/s12149-026-02177-1
Yurika Kitano, Kanae K. Miyake, Tomomi W. Nobashi, Takayoshi Ishimori, Ryusuke Nakamoto, Sho Koyasu, Masako Kataoka, Masakazu Toi, Yuji Nakamoto
{"title":"Response to the comment on “Locoregional indicators of systemic spread in breast cancer: insights from standard-of-care imaging and ¹⁸F-FDG PET/CT”","authors":"Yurika Kitano,&nbsp;Kanae K. Miyake,&nbsp;Tomomi W. Nobashi,&nbsp;Takayoshi Ishimori,&nbsp;Ryusuke Nakamoto,&nbsp;Sho Koyasu,&nbsp;Masako Kataoka,&nbsp;Masakazu Toi,&nbsp;Yuji Nakamoto","doi":"10.1007/s12149-026-02177-1","DOIUrl":"10.1007/s12149-026-02177-1","url":null,"abstract":"","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":"40 5","pages":"609 - 610"},"PeriodicalIF":2.5,"publicationDate":"2026-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147589490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multicenter evaluation of commercial AI for [18F]FDG PET/CT lesion detection. 商用人工智能在[18F]FDG PET/CT病变检测中的多中心评价
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-03-30 DOI: 10.1007/s12149-026-02199-9
Maxence Gambiez, Xavier Palard-Novello, Clémence Guéry, Etienne Marchal, Laurent Dercle, David Morland, Marc-Etienne Meyer, Olivier Humbert, Antoine Girard
{"title":"Multicenter evaluation of commercial AI for [<sup>18</sup>F]FDG PET/CT lesion detection.","authors":"Maxence Gambiez, Xavier Palard-Novello, Clémence Guéry, Etienne Marchal, Laurent Dercle, David Morland, Marc-Etienne Meyer, Olivier Humbert, Antoine Girard","doi":"10.1007/s12149-026-02199-9","DOIUrl":"https://doi.org/10.1007/s12149-026-02199-9","url":null,"abstract":"","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147571866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical efficacy of radium-223 in simulating real-world clinical practice: a meta-analysis. 镭223在模拟真实世界临床实践中的临床疗效:一项荟萃分析。
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-03-28 DOI: 10.1007/s12149-026-02200-5
Yen-Hsiang Chang, Li Yu Chen, Ya Ting Huang, Hao Lun Luo
{"title":"Clinical efficacy of radium-223 in simulating real-world clinical practice: a meta-analysis.","authors":"Yen-Hsiang Chang, Li Yu Chen, Ya Ting Huang, Hao Lun Luo","doi":"10.1007/s12149-026-02200-5","DOIUrl":"https://doi.org/10.1007/s12149-026-02200-5","url":null,"abstract":"","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147571848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书